Trading Strategies Aurobindo Pharma Secures USFDA Final Nod for Rivaroxaban 2.5mg – Strong Boost to Global Expansion Strategy! Aneri GuidelinesApril 14, 2025 🌐 Detailed Market Report: Aurobindo Pharma, a leading name in the global pharmaceutical landscape, has received a final approval from…
EnergyHealthcare Aurobindo Pharma’s Solar Power Acquisition – A Game-Changer or Just Another Deal? Aneri GuidelinesMarch 28, 2025 Aurobindo Pharma Limited, a major pharmaceutical company, has taken a strategic step toward sustainability by acquiring up to 26% stake…
HealthcareLarge Cap StocksStock Market Updates Aurobindo Pharma’s Subsidiary Curateq Allocates Convertible Shares, Alters Ownership Structure Aneri GuidelinesMarch 21, 2025 Report on Aurobindo Pharma’s Curateq Share Allotment 1. Key Announcement: Aurobindo Pharma’s wholly owned subsidiary, Curateq Biologics Private Limited, has…
